Therapeutic Effects of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Althea Med J 2025, 12 (3), 161-171. https://doi.org/10.15850/amj.v12n3.4209.